Get the Stockscreener App
3.22
10.31%
-0.37
After Hours:
3.15
-0.07
-2.17%
Exagen Inc stock is traded at $3.22, with a volume of 844.14K.
It is down -10.31% in the last 24 hours and down -4.17% over the past month.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
See More
Previous Close:
$3.59
Open:
$3.53
24h Volume:
844.14K
Relative Volume:
1.88
Market Cap:
$72.98M
Revenue:
$52.55M
Net Income/Loss:
$-23.69M
P/E Ratio:
-3.4255
EPS:
-0.94
Net Cash Flow:
$-15.29M
1W Performance:
-15.26%
1M Performance:
-4.17%
6M Performance:
-66.70%
1Y Performance:
+0.94%
1-Day Range:
$3.02
$3.59
1-Week Range:
$3.02
$3.80
52-Week Range:
$2.77
$12.23
Exagen Inc Stock (XGN) Company Profile
Name
Exagen Inc
Sector
Industry
Phone
(760) 560-1501
Address
1261 LIBERTY WAY, VISTA, CA
Compare XGN vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
3.22 | 81.36M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
518.84 | 192.62B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
202.00 | 144.77B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
618.92 | 51.65B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
118.11 | 34.09B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
315.59 | 31.30B | 3.17B | 642.63M | 516.49M | 10.77 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-11-25 | Initiated | B. Riley Securities | Buy |
| Jul-30-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-23-25 | Initiated | Craig Hallum | Buy |
| Aug-05-22 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Apr-15-21 | Initiated | Canaccord Genuity | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Jun-02-20 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-14-19 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-14-19 | Initiated | Cowen | Outperform |
| Oct-14-19 | Initiated | William Blair | Outperform |
View All
Exagen Inc Stock (XGN) Latest News
Exagen Inc. (NASDAQ:XGN) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
John Aballi Sells 15,698 Shares of Exagen (NASDAQ:XGN) Stock - MarketBeat
Exagen CEO Aballi sells $56,826 in shares - Investing.com Nigeria
Exagen CEO Aballi sells $56,826 in shares By Investing.com - Investing.com Australia
Exagen (XGN) CEO Aballi covers RSU taxes and buys shares via ESPP - Stock Titan
XGN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Exagen Inc. to Participate in Upcoming Investor Conferences - The Manila Times
CEO Change: Will Exagen Inc benefit from geopolitical trendsTreasury Yields & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Exagen (XGN) to Release Earnings on Tuesday - MarketBeat
Exagen Inc. (NASDAQ:XGN) Short Interest Update - MarketBeat
XGN Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Insider Selling: Exagen (NASDAQ:XGN) CEO Sells 11,430 Shares of Stock - MarketBeat
EXAGEN (XGN) CEO has 11,430 shares sold to cover RSU tax withholding - Stock Titan
Exagen (NASDAQ:XGN) Price Target Cut to $10.00 by Analysts at TD Cowen - Defense World
TD Cowen Issues Pessimistic Forecast for Exagen (NASDAQ:XGN) Stock Price - MarketBeat
Exagen (XGN) Rating Maintained, Price Target Lowered by TD Cowen - GuruFocus
Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026 - GlobeNewswire
Exagen: A Deep Dive into the Diagnostics Specialist's Fundamentals - AD HOC NEWS
What are Exagen Inc.’s recent SEC filings showingJuly 2025 Drop Watch & Low Risk Profit Maximizing Plans - mfd.ru
RTW INVESTMENTS, LP Reduces Stake in Exagen Inc: A Strategic Por - GuruFocus
How interest rate cuts could boost Exagen Inc. stockWeekly Investment Summary & Daily Momentum Trading Reports - mfd.ru
BTIG Sticks to Their Buy Rating for Exagen (XGN) - The Globe and Mail
Exagen (NASDAQ:XGN) Price Target Lowered to $10.00 at BTIG Research - MarketBeat
Exagen (XGN) Analyst Lowers Price Target, Maintains Buy Rating | - GuruFocus
Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates - MSN
Returns Recap: Can Exagen Inc maintain sales growthWeekly Investment Recap & Low Risk Profit Maximizing Plans - baoquankhu1.vn
What Analysts Think Is Changing The Story For Exagen (XGN) Now - Yahoo Finance
Exagen Inc. (NASDAQ:XGN) Short Interest Down 67.3% in January - MarketBeat
Aug EndMonth: Is NVMI exposed to political risk2025 Price Momentum & Daily Stock Trend Watchlist - baoquankhu1.vn
Exagen Inc. (NASDAQ:XGN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Trend Recap: Is Exagen Inc being accumulated by smart moneyWeekly Trade Recap & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Performance Recap: Is HBANM a speculative investmentRecession Risk & Technical Pattern Based Buy Signals - baoquankhu1.vn
Bearish Setup: What are ICCTs earnings expectationsWeekly Trade Summary & Accurate Buy Signal Alerts - baoquankhu1.vn
B. Riley Reaffirms Buy Rating for Exagen (NASDAQ:XGN) - Defense World
Short Interest in Exagen Inc. (NASDAQ:XGN) Expands By 65.7% - MarketBeat
B. Riley Cuts Price Target on Exagen to $8 From $18, Keeps Buy Rating - marketscreener.com
XGN: B. Riley Securities Lowers Price Target, Maintains Buy Rati - GuruFocus
Exagen's (XGN) "Buy" Rating Reaffirmed at B. Riley - MarketBeat
Is Exagen Inc. impacted by rising rates2025 Volume Leaders & High Accuracy Investment Signals - mfd.ru
How The Exagen (XGN) Story Is Shifting With A New Analyst Price Target - Yahoo Finance
Volume Recap: Does Crescent Capital BDC Inc stock reflect fundamentals2025 Earnings Impact & Daily Profit Focused Stock Screening - baoquankhu1.vn
Benign Growth For Exagen Inc. (NASDAQ:XGN) Underpins Stock's 26% Plummet - 富途牛牛
Trend Report: Will Exagen Inc benefit from current market trendsTrade Entry Summary & Daily Chart Pattern Signals - baoquankhu1.vn
Exagen Inc. (NASDAQ:XGN) Sees Large Growth in Short Interest - MarketBeat
Investors Don't See Light At End Of Exagen Inc.'s (NASDAQ:XGN) Tunnel And Push Stock Down 28% - Sahm
Selling Exagen Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - Sahm
Tech Rally: Is Exagen Inc. benefiting from innovation trends2025 Trading Volume Trends & Breakout Confirmation Alerts - baoquankhu1.vn
Exagen Inc. (NASDAQ:XGN) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
ETF Watch: How Exagen Inc stock benefits from global expansionJuly 2025 Technicals & Community Consensus Stock Picks - Bộ Nội Vụ
Published on: 2026-01-13 10:11:31 - ulpravda.ru
Analysts Are Bullish on These Healthcare Stocks: Exagen (XGN), Medline, Inc. Class A (MDLN) - The Globe and Mail
Exagen Inc Stock (XGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.14%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):